AAAAAA
Results:
1-9
|
Results: 9
Authors:
Hagele, G
Szakacs, Z
Ollig, J
Hermer, S
Pfaff, C
Citation: G. Hagele et al., NMR-controlled titrations: Characterizing aminophosphonates and related structures (vol 11, pg 578, 2000), HETEROAT CH, 12(2), 2001, pp. 118-118
Authors:
von Campenhausen, C
Pfaff, C
Schramme, J
Citation: C. Von Campenhausen et al., Three-dimensional interpretation of the color system of Aguilonius/Rubens 1613, COL RES APP, 26, 2001, pp. S17-S19
Authors:
Hagele, G
Szakacs, Z
Ollig, J
Hermens, S
Pfaff, C
Citation: G. Hagele et al., NMR-controlled titrations: Characterizing aminophosphonates and related structures, HETEROAT CH, 11(7), 2000, pp. 562-582
Authors:
Weitzman, AL
Shelton, G
Zuech, N
Owen, CE
Judge, T
Benson, M
Sawczuk, I
Katz, A
Olsson, CA
Bagiella, E
Pfaff, C
Newhouse, JH
Petrylak, DP
Citation: Al. Weitzman et al., Dexamethasone does not significantly contribute to the response rate of docetaxel and estramustine in androgen independent prostate cancer, J UROL, 163(3), 2000, pp. 834-837
Authors:
Vieira, A
Tovar, MA
Pfaff, C
Betancourt, P
Mendez, B
Lopez, CM
Machado, FJ
Goldwasser, J
de Agudelo, MMR
Houalla, M
Citation: A. Vieira et al., A study of manganese silicoaluminophosphate molecular sieves (vol 144, pg 101, 1999), J MOL CAT A, 149(1-2), 1999, pp. 323-323
Authors:
Vieira, A
Tovar, MA
Pfaff, C
Betancourt, P
Mendez, B
Lopez, CM
Machado, FJ
Goldwasser, J
de Agudelo, MMR
Houalla, M
Citation: A. Vieira et al., A study of manganese-silicoaluminophosphate molecular sieves, J MOL CAT A, 144(1), 1999, pp. 101-116
Authors:
Petrylak, DP
Macarthur, RB
O'Connor, J
Shelton, G
Judge, T
Balog, J
Pfaff, C
Bagiella, E
Heitjan, D
Fine, R
Zuech, N
Sawczuk, I
Benson, M
Olsson, CA
Citation: Dp. Petrylak et al., Phase I trial of docetaxel with estramustine in androgen-independent prostate cancer, J CL ONCOL, 17(3), 1999, pp. 958-967
Authors:
Llambias, FJG
Escalona, N
Pfaff, C
Scott, C
Goldwasser, J
Citation: Fjg. Llambias et al., Comparison of surface coverage values of tungsten-alumina catalysts determined by different methods, REACT KIN C, 66(2), 1999, pp. 225-229
Authors:
Petrylak, DP
Macarthur, R
O'Connor, J
Shelton, G
Weitzman, A
Judge, T
England-Owen, C
Zuech, N
Pfaff, C
Newhouse, J
Bagiella, E
Hetjan, D
Sawczuk, I
Benson, M
Olsson, C
Citation: Dp. Petrylak et al., Phase I/II studies of docetaxel (Taxotere) combined with estramustine in men with hormone-refractory prostate cancer, SEMIN ONCOL, 26(5), 1999, pp. 28-33
Risultati:
1-9
|